<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1886-5887</journal-id>
<journal-title><![CDATA[Revista de Bioética y Derecho]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Bioética y Derecho]]></abbrev-journal-title>
<issn>1886-5887</issn>
<publisher>
<publisher-name><![CDATA[Observatori de Bioètica i Dret - Cátedra UNESCO de Bioética]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1886-58872021000200009</article-id>
<article-id pub-id-type="doi">10.1344/rbd2021.52.34155</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Doenças raras e barreiras de comunicação: uma análise bioética]]></article-title>
<article-title xml:lang="es"><![CDATA[Enfermedades raras y barreras de comunicación: un análisis bioético]]></article-title>
<article-title xml:lang="en"><![CDATA[Rare diseases and communication barriers: a bioethical analysis]]></article-title>
<article-title xml:lang="ca"><![CDATA[Malalties rares i barreres de comunicació: una anàlisi bioètic]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rosaneli]]></surname>
<given-names><![CDATA[Caroline Filla]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Brotto]]></surname>
<given-names><![CDATA[Aline Maran]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[Marta Luciane]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Pontifícia Universidade Católica do Paraná (PUCPR)  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Pontifícia Universidade Católica do Paraná  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Pontifícia Universidade Católica do Paraná  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2021</year>
</pub-date>
<numero>52</numero>
<fpage>139</fpage>
<lpage>154</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1886-58872021000200009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1886-58872021000200009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1886-58872021000200009&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo Atualmente existem em média 300 milhões de pessoas com algum tipo de doença rara no mundo, essas doenças são progressivas, degenerativas e podem ser fatais, afetando em sua maioria crianças. As doenças raras fazem parte de um itinerário terapêutico muitas vezes longo e exaustivo. Quando se discute sobre doenças raras automaticamente deve-se pensar em uma tríade, pessoa com doença rara, família e profissionais da saúde. Para haver relação entre os três, é necessário haver comunicação. O objetivo deste estudo é analisar as barreiras comunicativas em saúde frente a tríade, paciente, família e equipe técnica ao longo do itinerário terapêutico. O método utilizado neste artigo é uma análise reflexiva sobre as barreiras de comunicação no nível acadêmico, técnico e pessoal. Criou-se uma síntese reflexiva sobre as barreiras de comunicação através de um olhar bioético, para transformar o espaço do outro através de ações que minimizem as vulnerabilidades sociais, individuais, institucionais e morais. Percebe-se que é necessário difundir estilos e práticas comunicativas para que seja mais natural no cotidiano da sociedade o uso de estratégias adaptativas de comunicação, bem como, intensificar a formação e informação técnica sobre os cuidados nas doenças raras, pois a comunicação inicia no ato do diagnóstico e perpetua por toda a vida. A bioética deve acolher, observar e agir através de estratégias justas, seguras e dignas. Logo, conclui-se que é de extrema importância discutir sobre as doenças raras no meio acadêmico, para que haja cada vez mais desenvolvimento crítico em relação a procedimentos técnicos e éticos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Actualmente hay un promedio de 300 millones de personas con algún tipo de enfermedad rara en el mundo. Estas son progresivas, degenerativas y pueden ser fatales, afectando mayoritariamente a los niños. Las enfermedades raras forman parte de un itinerario terapéutico que suele ser largo y exhaustivo. Cuando se habla de ellas, de forma automática se debería pensar en una tríada: persona con enfermedades raras, familiares y profesionales de la salud. Para tener una relación entre los tres, es necesaria la comunicación. El objetivo de este estudio es analizar las barreras comunicativas en salud frente a la tríada paciente, familia y equipo técnico a lo largo del itinerario terapéutico. El método utilizado en este artículo es un análisis reflexivo de las barreras de comunicación a nivel académico, técnico y personal. Se creó una síntesis reflexiva sobre las barreras comunicativas a través de una mirada bioética, para transformar el espacio del otro a través de acciones que minimicen las vulnerabilidades sociales, individuales, institucionales y morales. Se percibe que es necesario difundir estilos y prácticas comunicativas para que sea más natural en la vida cotidiana de la sociedad el uso de estrategias de comunicación adaptativa, así como la intensificación de la formación y la información técnica sobre la atención en enfermedades raras, ya que la comunicación se inicia en el momento del diagnóstico y se perpetúa a lo largo de la vida. La bioética debe acoger, observar y actuar a través de estrategias justas, seguras y dignas. Por tanto, se concluye que es de suma importancia discutir las enfermedades raras en la academia, por lo que existe un desarrollo cada vez más crítico en relación a los procedimientos técnicos y éticos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Currently there are an average of 300 million people with some type of rare disease in the world. These diseases are progressive, degenerative and can be fatal, affecting mostly children. Rare diseases are part of a therapeutic itinerary that is often long and exhaustive. When discussing rare diseases, automatically, you should think of a triad person with rare disease, family, and health professionals. In order to have a relationship between the three, communication is necessary. The objective of this paper is to analyze the communication barriers in health care for the triad patient, family, and technical team along the therapeutic itinerary. The method used in this article is a reflexive analysis of communication barriers at the academic, technical and personal levels. A reflexive synthesis about communication barriers was created through a bioethical perspective, to transform the space of the other through actions that minimize social, individual, institutional and moral vulnerabilities. It is perceived that it is necessary to disseminate communicative styles and practices in order to make the use of adaptative communication strategies more natural in the daily life of society, as well as the intensification of training and technical information about care in rare diseases, as communication starts at the moment of diagnosis and is perpetuates throughout life. Bioethics must embrace, observe and act through fair, safe and dignified strategies. Therefore, it is concluded that it is extremely important to discuss rare diseases in academia, so that there is an increasingly critical development in relation to technical and ethical procedures.]]></p></abstract>
<abstract abstract-type="short" xml:lang="ca"><p><![CDATA[Resum Actualment hi ha una mitjana de 300 milions de persones amb algun tipus de malaltia rara en el món. Aquestes són progressives, degeneratives i poden ser fatals, afectant majoritàriament els nens. Les malalties rares formen part d'un itinerari terapèutic que sol ser llarg i exhaustiu. Quan es parla de elles, de forma automàtica s'hauria de pensar en una tríade: persona amb malalties rares, familiars i professionals de la salut. Per a tenir una relació entre els tres, és necessària la comunicació. L'objectiu d'aquest estudi és analitzar les barreres comunicatives en salut enfront de la tríade pacient, família i equip tècnic al llarg de l'itinerari terapèutic. El mètode utilitzat en aquest article és una anàlisi reflexiva de les barreres de comunicació a nivell acadèmic, tècnic i personal. Es va crear una síntesi reflexiva sobre les barreres comunicatives a través d'una mirada bioètica, per a transformar l'espai de l'altre a través d'accions que minimitzin les vulnerabilitats socials, individuals, institucionals i morals. Es percep que és necessari difondre estils i pràctiques comunicatives perquè sigui més natural en la vida quotidiana de la societat l'ús d'estratègies de comunicació adaptativa, així com la intensificació de la formació i la informació tècnica sobre l'atenció en malalties estranyes, ja que la comunicació s'inicia en el moment del diagnòstic i es perpetua al llarg de la vida. La bioètica ha d'acollir, observar i actuar a través d'estratègies justes, segures i dignes. Per tant, es conclou que és de summa importància discutir les malalties rares en l'acadèmia, per la qual cosa existeix un desenvolupament cada vegada més crític en relació als procediments tècnics i ètics.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[doença rara]]></kwd>
<kwd lng="pt"><![CDATA[vulnerabilidade]]></kwd>
<kwd lng="pt"><![CDATA[bioética]]></kwd>
<kwd lng="pt"><![CDATA[comunicação]]></kwd>
<kwd lng="pt"><![CDATA[estratégia]]></kwd>
<kwd lng="pt"><![CDATA[saúde]]></kwd>
<kwd lng="pt"><![CDATA[direito]]></kwd>
<kwd lng="es"><![CDATA[enfermedad rara]]></kwd>
<kwd lng="es"><![CDATA[vulnerabilidad]]></kwd>
<kwd lng="es"><![CDATA[bioética]]></kwd>
<kwd lng="es"><![CDATA[comunicación]]></kwd>
<kwd lng="es"><![CDATA[estrategia]]></kwd>
<kwd lng="es"><![CDATA[salud]]></kwd>
<kwd lng="es"><![CDATA[derecho]]></kwd>
<kwd lng="en"><![CDATA[Rare disease]]></kwd>
<kwd lng="en"><![CDATA[vulnerability]]></kwd>
<kwd lng="en"><![CDATA[bioethics]]></kwd>
<kwd lng="en"><![CDATA[communication]]></kwd>
<kwd lng="en"><![CDATA[strategy]]></kwd>
<kwd lng="en"><![CDATA[health]]></kwd>
<kwd lng="en"><![CDATA[right]]></kwd>
<kwd lng="ca"><![CDATA[malaltia rara]]></kwd>
<kwd lng="ca"><![CDATA[vulnerabilitat]]></kwd>
<kwd lng="ca"><![CDATA[bioètica]]></kwd>
<kwd lng="ca"><![CDATA[comunicació]]></kwd>
<kwd lng="ca"><![CDATA[estratègia]]></kwd>
<kwd lng="ca"><![CDATA[salut]]></kwd>
<kwd lng="ca"><![CDATA[dret]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Afonso]]></surname>
<given-names><![CDATA[SBC]]></given-names>
</name>
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mitre]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Narrativas da experiência de pais de crianças com fibrose cística]]></article-title>
<source><![CDATA[Interface Comunic, Saúde Educ]]></source>
<year>2015</year>
<volume>19</volume>
<numero>55</numero>
<issue>55</issue>
<page-range>1077-88</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amaral]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Rego]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Doenças raras na agenda da inovação em saúde: avanços e desafios na fibrose cística]]></article-title>
<source><![CDATA[Cad. Saúde Pública]]></source>
<year>2020</year>
<volume>36</volume>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aureliano]]></surname>
<given-names><![CDATA[WA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trajetórias terapêuticas familiares: doenças raras hereditárias como sofrimento de longa duração]]></article-title>
<source><![CDATA[Ciênc. saúde coletiva]]></source>
<year>2018</year>
<volume>23</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>369-79</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Reis]]></surname>
<given-names><![CDATA[KMN]]></given-names>
</name>
<name>
<surname><![CDATA[Lomba]]></surname>
<given-names><![CDATA[GO]]></given-names>
</name>
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[GV]]></given-names>
</name>
<name>
<surname><![CDATA[Braga]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rede de apoio e apoio social às crianças com necessidades especiais de saúde]]></article-title>
<source><![CDATA[Rev Rene]]></source>
<year>2016</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>60-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baxter]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rare or orphan diseases a useful political concept]]></article-title>
<source><![CDATA[Dev Med Child Neurol]]></source>
<year>2012</year>
<volume>54</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>579</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Especializada e Temática. Coordenação Geral de Média e Alta Complexidade</collab>
<source><![CDATA[Diretrizes para Atenção Integral às Pessoas com Doenças Raras no Sistema Único de Saúde - SUS / Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Especializada e Temática. Coordenação Geral de Média e Alta Complexidade]]></source>
<year>2014</year>
<publisher-name><![CDATA[Brasília]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brotto]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Rosaneli]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Piloto]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identificação e pertencimento: a importância de construir laços que aproximam pessoas com doenças raras]]></article-title>
<source><![CDATA[Apae Ciência]]></source>
<year>2020</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-16</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cerqueira]]></surname>
<given-names><![CDATA[MMF]]></given-names>
</name>
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[RO]]></given-names>
</name>
<name>
<surname><![CDATA[Aguiar]]></surname>
<given-names><![CDATA[MGG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experiências vividas por mães de crianças com deficiência intelectual nos itinerários terapêuticos]]></article-title>
<source><![CDATA[Ciênc. saúde coletiva]]></source>
<year>2016</year>
<volume>21</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>3223-32</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chernicharo]]></surname>
<given-names><![CDATA[IM]]></given-names>
</name>
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[FDS]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Humanização no cuidado de enfermagem: contribuição ao debate sobre a Política Nacional de Humanização]]></article-title>
<source><![CDATA[Rev. bras. Enferm]]></source>
<year>2013</year>
<volume>66</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>564-70</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>Comissão Européia</collab>
<source><![CDATA[Rare diseases]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dominguez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pessoas afetadas com doenças complexas e pouco conhecidas se mobilizam para viabilizar políticas públicas e combater preconceitos]]></article-title>
<source><![CDATA[Radis]]></source>
<year>2015</year>
<numero>149</numero>
<issue>149</issue>
<page-range>12-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Velloso]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linguagem e comunicação de pessoas com deficiência intelectual e suas contribuições para a construção da autonomia]]></article-title>
<source><![CDATA[Inc.Soc]]></source>
<year>2017</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>88-96</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<collab>EUA. One Hundred Seventh Congress of the United States of America</collab>
<source><![CDATA[To amend the Public Health Service Act to establish an Office of Rare Diseases at the National Institutes of Health, and for other purposes]]></source>
<year>2002</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<collab>Eurodis</collab>
<source><![CDATA[Medicamentos órfãos]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Felipe]]></surname>
<given-names><![CDATA[RNR]]></given-names>
</name>
<name>
<surname><![CDATA[Rosaneli]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Cunha]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
<name>
<surname><![CDATA[Munhoz]]></surname>
<given-names><![CDATA[CJM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatores de vulnerabilidades em itinerários terapêuticos de doenças raras: uma revisão integrativa]]></article-title>
<source><![CDATA[Revista Saúde e Desenvolvimento Humano]]></source>
<year>2020</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-13</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Cini]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Zanatta]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Nohama]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hashimoto]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[VB]]></given-names>
</name>
<name>
<surname><![CDATA[Rosaneli]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Panorama da nutrigenômica no Brasil sob a perspectiva da Bioética]]></article-title>
<source><![CDATA[Revista Latinoamericana Bioetica]]></source>
<year>2020</year>
<numero>20</numero>
<issue>20</issue>
<page-range>27-48</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hyry]]></surname>
<given-names><![CDATA[HI]]></given-names>
</name>
<name>
<surname><![CDATA[Cox]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Roos]]></surname>
<given-names><![CDATA[JCP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Brexit and rare diseases: big risk, bigger opportunity?]]></article-title>
<source><![CDATA[Current Medical Research and Opinion]]></source>
<year>2017</year>
<volume>33</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>783-4</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iriart]]></surname>
<given-names><![CDATA[JAB]]></given-names>
</name>
<name>
<surname><![CDATA[Nucci]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Muniz]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Viana]]></surname>
<given-names><![CDATA[GB]]></given-names>
</name>
<name>
<surname><![CDATA[Aureliano]]></surname>
<given-names><![CDATA[WA]]></given-names>
</name>
<name>
<surname><![CDATA[Gibbon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Da busca pelo diagnóstico às incertezas do tratamento: desafios do cuidado para as doenças genéticas raras no Brasil]]></article-title>
<source><![CDATA[Ciênc. saúde colet]]></source>
<year>2019</year>
<volume>24</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>3637-50</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Komarov]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
<name>
<surname><![CDATA[Krasilnikova]]></surname>
<given-names><![CDATA[EI]]></given-names>
</name>
<name>
<surname><![CDATA[Zhulev]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
<name>
<surname><![CDATA[Zinchenko]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The analysis of detection of rare diseases not included into listings of orphan diseases with preferential medication support]]></article-title>
<source><![CDATA[Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med]]></source>
<year>2020</year>
<volume>28</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>893-902</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moreira]]></surname>
<given-names><![CDATA[MCN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trajetórias e experiências morais de adoecimento raro e crônico em biografias: um ensaio teórico]]></article-title>
<source><![CDATA[Ciênc. saúde coletiva]]></source>
<year>2019</year>
<volume>24</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>3651-61</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<collab>Orphanet</collab>
<source><![CDATA[Portal para doenças raras e os medicamentos órfãos]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pais-Ribeiro]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<source><![CDATA[Introdução à Psicologia da Saúde]]></source>
<year>2007</year>
<edition>2ª</edition>
<publisher-loc><![CDATA[Coimbra ]]></publisher-loc>
<publisher-name><![CDATA[Quarteto]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rimaudo]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Llobeta]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vulnerabilidade e sujeito da pesquisa com seres humanos: uma reflexão]]></article-title>
<source><![CDATA[Rev Bio y Der]]></source>
<year>2021</year>
<numero>51</numero>
<issue>51</issue>
<page-range>225-41</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sayago]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[O acesso global e nacional ao tratamento da hemofilia: reflexões da bioética crítica sobre exclusão em saúde]]></article-title>
<source><![CDATA[Interface]]></source>
<year>2020</year>
<volume>24</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1-15</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soares]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Araújo]]></surname>
<given-names><![CDATA[LFS]]></given-names>
</name>
<name>
<surname><![CDATA[Bellato]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cuidar na situação de adoecimento raro: vivência da família e sua busca por amparo dos serviços de saúde]]></article-title>
<source><![CDATA[Saúde soc]]></source>
<year>2016</year>
<volume>25</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1017-30</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Triclin-Conseil]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Les rencontres RARE 2017 vues du point de vue des associations de malades]]></article-title>
<source><![CDATA[Med Sci]]></source>
<year>2018</year>
<volume>34</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-5</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Varela]]></surname>
<given-names><![CDATA[RCB]]></given-names>
</name>
<name>
<surname><![CDATA[Oliver]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A utilização de Tecnologia Assistiva na vida cotidiana de crianças com deficiência]]></article-title>
<source><![CDATA[Ciênc. saúde coletiva]]></source>
<year>2013</year>
<volume>18</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1773-84</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
